Consistent with our findings, Rao et al. also reported that inhibition of ileal ASBT performed more FXR agonistic bile acids and protected against NAFLD in high-fat diet mice (Rao et al., 2016). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.